Search for: "Williams v. Peters" Results 601 - 620 of 998
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2022, 4:06 pm by INFORRM
On 23-24 June 2022, there were applications in Piepenbrock v LSE before Heather Williams J. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
9 Jul 2013, 12:32 pm by Tom Goldstein and Dan Stein
Bush nominated both Gibson Dunn partner Miguel Estrada and Sidley Austin partner Peter Keisler to the court. [read post]
26 Mar 2017, 4:06 pm by INFORRM
The Defendants are led by William Whatcott. [read post]
20 Jul 2020, 3:48 am by Peter Mahler
So long as the corporation can articulate any valid business purpose for the freeze-out, the court will defer to its business judgment and permit it (see Alpert v 28 Williams St. [read post]
5 Dec 2022, 12:49 am by INFORRM
 Kenya Citizens and data privacy experts have expressed concerns about a mobile-loan scheme which was launched by Kenyan President William Ruto, Quartz reports. [read post]
3 Oct 2022, 12:12 pm by INFORRM
Peter Dutton has discontinued his High Court Appeal against Shane Bassi. [read post]
15 Apr 2012, 1:00 am by Clara Altman
 In The New Republic: The Book Peter Green reviews Jennifer Roberts’s Herodotus: A Very Short Introduction (Oxford University Press). [read post]
29 Sep 2008, 4:00 am
  The case was People v. [read post]
20 Feb 2021, 1:51 pm by admin
The editorial board also includes some high-volume testifying plaintiffs expert witnesses: Peter Infante, of Peter F. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]